Activin βC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate

被引:53
作者
Mellor, SL
Ball, EMA
O'Connor, AE
Ethier, JF
Cranfield, M
Schmitt, JF
Phillips, DJ
Groome, NP
Risbridger, GP
机构
[1] Monash Univ, Monash Med Ctr, Monash Inst Reprod & Dev, Ctr Urol Res, Clayton, Vic 3168, Australia
[2] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[3] Oxford Brookes Univ, Sch Biol & Mol Sci, Oxford OX3 0BP, England
关键词
D O I
10.1210/en.2003-0225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activins are formed by dimerization of beta-subunits and, as members of the TGF-beta superfamily, have diverse roles as potent growth and differentiation factors. As the biological function of the activin C homodimer (beta(C)-beta(C)) is unknown, we sought to compare activin A (beta(A)-beta(A)), B (beta(B)-beta(B)), and C homodimer bioactivities and to investigate the consequences of activin beta(C)-subunit overexpression in prostate tumor cells. Exogenous activin A and B homodimers inhibited cell growth and activated activin-responsive promoters. In contrast, the activin C homodimer was unable to elicit these responses. We previously showed that the activin beta(C)-subunit heterodimerized with activin beta(A) in vitro to form activin AC. Therefore, we hypothesize that the activin beta(C)-subunit regulates the levels of bioactive activin A by the formation of activin AC heterodimers. To test this hypothesis, we measured activin AC heterodimer production using a novel specific two-site ELISA that we developed for this purpose. In the PC3 human prostate tumor cell line, activin beta(C)-subunit overexpression increased activin AC heterodimer levels, concomitantly reduced activin A levels, and decreased activin signaling. Overall, these data are consistent with a role for the activin beta(C)-subunit as a regulatory mechanism to reduce activin A secretion via intracellular heterodimerization.
引用
收藏
页码:4410 / 4419
页数:10
相关论文
共 39 条
[1]  
Alarid ET, 1996, DEVELOPMENT, V122, P3319
[2]   A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse [J].
Nolan, PM ;
Peters, J ;
Strivens, M ;
Rogers, D ;
Hagan, J ;
Spurr, N ;
Gray, IC ;
Vizor, L ;
Brooker, D ;
Whitehill, E ;
Washbourne, R ;
Hough, T ;
Greenaway, S ;
Hewitt, M ;
Liu, XH ;
McCormack, S ;
Pickford, K ;
Selley, R ;
Wells, C ;
Tymowska-Lalanne, Z ;
Roby, P ;
Glenister, P ;
Thornton, C ;
Thaung, C ;
Stevenson, JA ;
Arkell, R ;
Mburu, P ;
Hardisty, R ;
Kiernan, A ;
Erven, H ;
Steel, KP ;
Voegeling, S ;
Guenet, JL ;
Nickols, C ;
Sadri, R ;
Naase, M ;
Isaacs, A ;
Davies, K ;
Browne, M ;
Fisher, EMC ;
Martin, J ;
Rastan, S ;
Brown, SDM ;
Hunter, J .
NATURE GENETICS, 2000, 25 (04) :440-443
[3]   TYPE-I RECEPTORS SPECIFY GROWTH-INHIBITORY AND TRANSCRIPTIONAL RESPONSES TO TRANSFORMING GROWTH-FACTOR-BETA AND ACTIVIN [J].
CARCAMO, J ;
WEIS, FMB ;
VENTURA, F ;
WIESER, R ;
WRANA, JL ;
ATTISANO, L ;
MASSAGUE, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3810-3821
[4]   Smad4 and FAST-1 in the assembly of activin-responsive factor [J].
Chen, X ;
Weisberg, E ;
Fridmacher, V ;
Watanabe, M ;
Naco, G ;
Whitman, M .
NATURE, 1997, 389 (6646) :85-89
[5]   A transcriptional partner for MAD proteins in TGF-beta signalling [J].
Chen, X ;
Rubock, MJ ;
Whitman, M .
NATURE, 1996, 383 (6602) :691-696
[6]   Activin inhibition of prostate cancer cell growth: Selective actions on androgen-responsive LNCaP cells [J].
Dalkin, AC ;
Gilrain, JT ;
Bradshaw, D ;
Myers, CE .
ENDOCRINOLOGY, 1996, 137 (12) :5230-5235
[7]   Activin A and follistatin: their role in the acute phase reaction and inflammation [J].
de Kretser, DM ;
Hedger, MP ;
Phillips, DJ .
JOURNAL OF ENDOCRINOLOGY, 1999, 161 (02) :195-198
[8]   Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): Regulation by cell surface follistatin [J].
Delbaere, A ;
Sidis, Y ;
Schneyer, AL .
ENDOCRINOLOGY, 1999, 140 (06) :2463-2470
[9]   Is gonadotrope expression of the gonadotropin releasing hormone receptor gene mediated by autocrine/paracrine stimulation of an activin response element? [J].
Duval, DL ;
Ellsworth, BS ;
Clay, CM .
ENDOCRINOLOGY, 1999, 140 (04) :1949-1952
[10]   Transforming growth factor-β modulates inhibin a bioactivity in the LβT2 gonadotrope cell line by competing for binding to betaglycan [J].
Ethier, JF ;
Farnworth, PG ;
Findlay, JK ;
Ooi, GT .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (12) :2754-2763